Stock Events

Stock Events

Search...

Sage Therapeutics (SAGE) Q2 2024 Earnings

25AprConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-3.37

-2.43

-1.49

-0.55

Details

Expected EPS

-1.648889

Actual EPS

-1.8

Surprise EPS

-0.15

Surprise Percent

+9.16%

Description

Sage Therapeutics (SAGE) has reported earnings of -1.8 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.